\-\ Texto\\:\\ \ \(0\)\
\-\ ruq\\ tenderness\\.\ \(0\)\
\-\ \\<li\\>ca\\ 19\\-9\\:\\ 514\\ \\(0\\-36\\)\ \(0\)\
\-\ \\<li\\>ast\\:\\ 32\ \(0\)\
\-\ \\<li\\>alt\\:\\ 53\ \(0\)\
\-\ \\<li\\>alk\\ phos\\:\\ 118\ \(0\)\
\-\ \\<li\\>amylase\\:\\ 56\ \(0\)\
\-\ \\<li\\>lipase\\:\\ 129\ \(0\)\
\-\ \\<li\\>afp\\ 6\\.6\\ \\(0\\-10\\)\ \(0\)\
\-\ \\<li\\>dea\\ 3\\.0\\ \\(0\\-3\\.4\\)\ \(0\)\
\-\ us\\ guided\\ biopsy\\ reported\\ as\\ moderately\\ differentiated\\ adenocarcinoma\\.\ \(0\)\
\-\ unfortunately\\,\\ this\\ lesion\\ is\\ non\\-resectable\\ due\\ to\\ other\\ coexisting\\ disease\\.\\ \\ the\\ only\\ chance\\ for\\ cure\\ is\\ complete\\ resection\\.\ \(0\)\
\-\ 4x4cm\\ hepatic\\ mass\\ with\\ necrotic\\ center\ \(1\)\
\-\ both\\ early\\ and\\ delayed\\ enhancement\ \(1\)\
\-\ associated\\ left\\ portal\\ vein\\ thrombosis\\ and\\ left\\ hepatic\\ lobe\\ atrophy\\.\ \(1\)\
\-\ ultrasound\\ images\\ of\\ biopsy\\ of\\ heterogeneous\\ liver\\ mass\\.\ \(0\)\
\-\ cholangiocarcinoma\\ \\-\\ radiographic\\ appearance\\ and\\ biopsy\ \(0\)\
\-\ cholangiocarcinoma\ \(16\)\
\-\ hepatocellular\\ carcinoma\ \(28\)\
\-\ abscess\ \(594\)\
\-\ metastatic\\ neoplasm\ \(2\)\
\-\ 84\\ year\\ old\\ white\\ male\\ with\\ vague\\ ruq\\ abdominal\\ pain\\ and\\ elevated\\ ca\\ 19\\-9\\ marker\\.\ \(0\)\
\-\ non\\-resectable\\ due\\ to\\ comorbidities\\.\ \(0\)\
\-\ the\\ only\\ chance\\ for\\ cure\\ is\\ complete\\ resection\\.\\ palliative\\ care\\ consists\\ of\\ ercp\\ or\\ pct\\ stenting\\ to\\ relieve\\ obstruction\\,\\ possible\\ chemo\\ with\\ 5fu\\ and\\ radioablation\\.\\ pain\\ control\\ with\\ possible\\ celiac\\ plexus\\ block\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ li\\:\\ 0\\.1916984651336919\ \(0\)\
\-\ \\<\\:\\ 0\\.1388659169474438\ \(0\)\
\-\ \\>\\:\\ 0\\.11954389535446587\ \(0\)\
\-\ non\\-resectable\\:\\ 0\\.07820235855628008\ \(0\)\
\-\ 19\\-9\\:\\ 0\\.07585347906876208\ \(0\)\
\-\ cure\\:\\ 0\\.06755392790703292\ \(0\)\
\-\ chance\\:\\ 0\\.05891202735892945\ \(0\)\
\-\ cholangiocarcinoma\\:\\ 0\\.056647697047172124\ \(0\)\
\-\ ruq\\:\\ 0\\.05061247619720029\ \(0\)\
\-\ biopsy\\:\\ 0\\.047868840657422536\ \(0\)\
\-\ 514\\:\\ 0\\.04639746538929736\ \(0\)\
\-\ dea\\:\\ 0\\.04639746538929736\ \(0\)\
\-\ 0\\-3\\.4\\:\\ 0\\.04639746538929736\ \(0\)\
\-\ coexisting\\:\\ 0\\.04639746538929736\ \(0\)\
\-\ 4x4cm\\:\\ 0\\.04639746538929736\ \(0\)\
\-\ pct\\:\\ 0\\.04639746538929736\ \(0\)\
\-\ 5fu\\:\\ 0\\.04639746538929736\ \(0\)\
\-\ 0\\-36\\:\\ 0\\.0427493223337187\ \(0\)\
\-\ ca\\:\\ 0\\.04188670017910548\ \(0\)\
\-\ radioablation\\:\\ 0\\.04061529544893888\ \(0\)\
\-\ 118\\:\\ 0\\.03910117927814004\ \(0\)\
\-\ 6\\.6\\:\\ 0\\.03910117927814004\ \(0\)\
\-\ 0\\-10\\:\\ 0\\.03910117927814004\ \(0\)\
\-\ hepatic\\:\\ 0\\.03756309844006329\ \(0\)\
\-\ \\:\\:\\ 0\\.035692888926021\ \(0\)\
\-\ 129\\:\\ 0\\.03545303622256138\ \(0\)\
\-\ comorbidities\\:\\ 0\\.03483312550858041\ \(0\)\
\-\ chemo\\:\\ 0\\.03331900933778156\ \(0\)\
\-\ complete\\:\\ 0\\.03165658877880057\ \(0\)\
\-\ possible\\:\\ 0\\.030294549672463915\ \(0\)\
\-\ ercp\\:\\ 0\\.0301288208979378\ \(0\)\
\-\ marker\\:\\ 0\\.029249588873394818\ \(0\)\
\-\ stenting\\:\\ 0\\.029249588873394818\ \(0\)\
\-\ block\\:\\ 0\\.02905095556822194\ \(0\)\
\-\ 84\\:\\ 0\\.028323848523586062\ \(0\)\
\-\ resection\\:\\ 0\\.02805174374231809\ \(0\)\
\-\ 3\\.0\\:\\ 0\\.027837673154475457\ \(0\)\
\-\ relieve\\:\\ 0\\.027837673154475457\ \(0\)\
\-\ amylase\\:\\ 0\\.027685107170932022\ \(0\)\
\-\ afp\\:\\ 0\\.027685107170932022\ \(0\)\
\-\ celiac\\:\\ 0\\.027685107170932022\ \(0\)\
\-\ lipase\\:\\ 0\\.027536839397423095\ \(0\)\
\-\ guided\\:\\ 0\\.02739263427011723\ \(0\)\
\-\ palliative\\:\\ 0\\.02739263427011723\ \(0\)\
\-\ only\\:\\ 0\\.027046438510367744\ \(0\)\
\-\ alk\\:\\ 0\\.02624672119724949\ \(0\)\
\-\ phos\\:\\ 0\\.02624672119724949\ \(0\)\
\-\ hepatocellular\\:\\ 0\\.02591420066239932\ \(0\)\
\-\ unfortunately\\:\\ 0\\.02580787062388606\ \(0\)\
\-\ moderately\\:\\ 0\\.02570364626969564\ \(0\)\
\-\ consists\\:\\ 0\\.024675705468007403\ \(0\)\
\-\ necrotic\\:\\ 0\\.0245914931451314\ \(0\)\
\-\ ast\\:\\ 0\\.02442700607405716\ \(0\)\
\-\ alt\\:\\ 0\\.02442700607405716\ \(0\)\
\-\ 53\\:\\ 0\\.024267504234608064\ \(0\)\
\-\ vague\\:\\ 0\\.024189530098896798\ \(0\)\
\-\ differentiated\\:\\ 0\\.024036964115353363\ \(0\)\
\-\ due\\:\\ 0\\.024002917399503575\ \(0\)\
\-\ 56\\:\\ 0\\.023673843739106252\ \(0\)\
\-\ portal\\:\\ 0\\.023673843739106252\ \(0\)\
\-\ atrophy\\:\\ 0\\.02320420619316971\ \(0\)\
\-\ 32\\:\\ 0\\.022429692275610303\ \(0\)\
\-\ center\\:\\ 0\\.02205550321411698\ \(0\)\
\-\ plexus\\:\\ 0\\.021853049104497008\ \(0\)\
\-\ control\\:\\ 0\\.020502828937570387\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.01942923391875389\ \(0\)\
\-\ thrombosis\\:\\ 0\\.019305389195542342\ \(0\)\
\-\ us\\:\\ 0\\.01886531477427322\ \(0\)\
\-\ delayed\\:\\ 0\\.01830515970665884\ \(0\)\
\-\ radiographic\\:\\ 0\\.01707033890415123\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.016537869246289503\ \(0\)\
\-\ early\\:\\ 0\\.016448205103381252\ \(0\)\
\-\ reported\\:\\ 0\\.01639513079250427\ \(0\)\
\-\ vein\\:\\ 0\\.01627333327375851\ \(0\)\
\-\ care\\:\\ 0\\.01622198498457238\ \(0\)\
\-\ obstruction\\:\\ 0\\.01586000025573387\ \(0\)\
\-\ liver\\:\\ 0\\.015506429004382755\ \(0\)\
\-\ neoplasm\\:\\ 0\\.0153166135574312\ \(0\)\
\-\ elevated\\:\\ 0\\.015259559796626647\ \(0\)\
\-\ white\\:\\ 0\\.014916337961642198\ \(0\)\
\-\ abscess\\:\\ 0\\.014220190758601406\ \(0\)\
\-\ tenderness\\:\\ 0\\.013678485909903332\ \(0\)\
\-\ ultrasound\\:\\ 0\\.013342750447401595\ \(0\)\
\-\ appearance\\:\\ 0\\.012862666193340219\ \(0\)\
\-\ carcinoma\\:\\ 0\\.012746987736925612\ \(0\)\
\-\ mass\\:\\ 0\\.012510115862605942\ \(0\)\
\-\ lobe\\:\\ 0\\.012101712357492285\ \(0\)\
\-\ enhancement\\:\\ 0\\.012055204032226504\ \(0\)\
\-\ both\\:\\ 0\\.011485263108874324\ \(0\)\
\-\ \\(\\:\\ 0\\.011405711467008325\ \(0\)\
\-\ metastatic\\:\\ 0\\.011321628440084686\ \(0\)\
\-\ \\)\\:\\ 0\\.011266384612315343\ \(0\)\
\-\ abdominal\\:\\ 0\\.011241680200642711\ \(0\)\
\-\ pain\\:\\ 0\\.01098534913190247\ \(0\)\
\-\ associated\\:\\ 0\\.0106129608521458\ \(0\)\
\-\ other\\:\\ 0\\.010366518677381309\ \(0\)\
\-\ left\\:\\ 0\\.01006426599234647\ \(0\)\
\-\ \\-\\:\\ 0\\.00964067609846507\ \(0\)\
\-\ lesion\\:\\ 0\\.00916081697894976\ \(0\)\
\-\ is\\:\\ 0\\.008878275448179878\ \(0\)\
\-\ images\\:\\ 0\\.008627704694470285\ \(0\)\
\-\ male\\:\\ 0\\.008132660725723544\ \(0\)\
\-\ for\\:\\ 0\\.007674822617291738\ \(0\)\
\-\ disease\\:\\ 0\\.007351250216924759\ \(0\)\
\-\ as\\:\\ 0\\.006803039504705935\ \(0\)\
\-\ to\\:\\ 0\\.006743180659626099\ \(0\)\
\-\ or\\:\\ 0\\.0052711723629668816\ \(0\)\
\-\ this\\:\\ 0\\.005058616912179647\ \(0\)\
\-\ year\\:\\ 0\\.005032132996173235\ \(0\)\
\-\ and\\:\\ 0\\.0047370790982162745\ \(0\)\
\-\ old\\:\\ 0\\.0046049189308539715\ \(0\)\
\-\ \\,\\:\\ 0\\.0028495796370240777\ \(0\)\
\-\ with\\:\\ 0\\.0024632458124187314\ \(0\)\
\-\ \\.\\:\\ 0\\.002055236300372679\ \(0\)\
\-\ of\\:\\ 0\\.0018395336968103438\ \(0\)\
\-\ the\\:\\ 0\\.0014552556284592188\ \(0\)\
